These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27149514)

  • 1. Abandonment of Treatment for Latent Tuberculosis Infection and Socioeconomic Factors in Children and Adolescents: Rio De Janeiro, Brazil.
    Mendonça AM; Kritski AL; Land MG; Sant'Anna CC
    PLoS One; 2016; 11(5):e0154843. PubMed ID: 27149514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-completion of latent tuberculous infection treatment among children in Rio de Janeiro State, Brazil.
    Silva AP; Hill P; Belo MT; Rabelo SG; Menzies D; Trajman A
    Int J Tuberc Lung Dis; 2016 Apr; 20(4):479-86. PubMed ID: 26970157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis contact tracing among children and adolescent referred to children's hospital in Rio de Janeiro, Brazil.
    Mendonça AM; Kritski AL; Sant'Anna CC
    Braz J Infect Dis; 2015; 19(3):296-301. PubMed ID: 25636186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda.
    Sensalire S; Karungi Karamagi Nkolo E; Nabwire J; Lawino A; Kiragga D; Muhire M; Kadama H; Katureebe C; Namuwenge P; Musinguzi J; Calnan J; Seyoum D
    AIDS Res Ther; 2020 May; 17(1):28. PubMed ID: 32460788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contact evaluation and isoniazid preventive therapy among close and household contacts of tuberculosis patients in Lima, Peru: an analysis of routine data.
    Otero L; Battaglioli T; Ríos J; De la Torre Z; Trocones N; Ordoñez C; Seas C; Van der Stuyft P
    Trop Med Int Health; 2020 Mar; 25(3):346-356. PubMed ID: 31758837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil.
    Golub JE; Saraceni V; Cavalcante SC; Pacheco AG; Moulton LH; King BS; Efron A; Moore RD; Chaisson RE; Durovni B
    AIDS; 2007 Jul; 21(11):1441-8. PubMed ID: 17589190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting uptake and completion of isoniazid preventive therapy among HIV-infected children at a national referral hospital, Kenya: a mixed quantitative and qualitative study.
    Ngugi SK; Muiruri P; Odero T; Gachuno O
    BMC Infect Dis; 2020 Apr; 20(1):294. PubMed ID: 32664847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for treatment default in close contacts with latent tuberculous infection.
    Fiske CT; Yan FX; Hirsch-Moverman Y; Sterling TR; Reichler MR;
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):421-7. PubMed ID: 24670696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Completion of isoniazid preventive therapy for latent tuberculosis infection among children and adolescents compared to adults living with HIV in Kinshasa, Democratic Republic of the Congo.
    Bidashimwa D; Ditekemena JD; Sigwadhi LN; Nkuta LM; Engetele E; Kilundu A; Chabikuli ON; Nachega JB
    Trop Med Int Health; 2024 Feb; 29(2):88-95. PubMed ID: 38123460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacillus Calmette-Guérin and isoniazid preventive therapy protect contacts of patients with tuberculosis.
    Zelner JL; Murray MB; Becerra MC; Galea J; Lecca L; Calderon R; Yataco R; Contreras C; Zhang Z; Grenfell BT; Cohen T
    Am J Respir Crit Care Med; 2014 Apr; 189(7):853-9. PubMed ID: 24592878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania.
    Shayo GA; Moshiro C; Aboud S; Bakari M; Mugusi FM
    BMC Infect Dis; 2015 Aug; 15():368. PubMed ID: 26306511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of isoniazid preventive therapy failure in child household contacts with infectious tuberculosis in high burden settings in Nairobi, Kenya - a cohort study.
    Okwara FN; Oyore JP; Were FN; Gwer S
    BMC Infect Dis; 2017 Sep; 17(1):623. PubMed ID: 28915796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of isoniazid preventive therapy on immune responses to mycobacterium tuberculosis: an open label randomised, controlled, exploratory study.
    Biraro IA; Egesa M; Kimuda S; Smith SG; Toulza F; Levin J; Joloba M; Katamba A; Cose S; Dockrell HM; Elliott AM
    BMC Infect Dis; 2015 Oct; 15():438. PubMed ID: 26493989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania.
    Hunter OF; Kyesi F; Ahluwalia AK; Daffé ZN; Munseri P; von Reyn CF; Adams LV
    BMC Infect Dis; 2020 Oct; 20(1):738. PubMed ID: 33028260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study.
    Sabasaba A; Mwambi H; Somi G; Ramadhani A; Mahande MJ
    BMC Infect Dis; 2019 Jan; 19(1):62. PubMed ID: 30654753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of tuberculosis screening and isoniazid treatment in the TB/HIV in Rio (THRio) Study.
    Azadi M; Bishai DM; Dowdy DW; Moulton LH; Cavalcante S; Saraceni V; Pacheco AG; Cohn S; Chaisson RE; Durovni B; Golub JE
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1443-8. PubMed ID: 25517809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of treatment interruption among latently infected tuberculosis cases treated with a nine-month course of daily isoniazid: findings from a time to event analysis.
    Séraphin MN; Hsu H; Chapman HJ; de Andrade Bezerra JL; Johnston L; Yang Y; Lauzardo M
    BMC Public Health; 2019 Sep; 19(1):1214. PubMed ID: 31481046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effect of isoniazid preventive therapy and antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia.
    Yirdaw KD; Jerene D; Gashu Z; Edginton ME; Kumar AM; Letamo Y; Feleke B; Teklu AM; Zewdu S; Weiss B; Ruff A
    PLoS One; 2014; 9(8):e104557. PubMed ID: 25105417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of universal isoniazid preventive therapy among HIV-infected pregnant women in South Africa.
    Kim HY; Hanrahan CF; Martinson N; Golub JE; Dowdy DW
    Int J Tuberc Lung Dis; 2018 Dec; 22(12):1435-1442. PubMed ID: 30606315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latent tuberculosis infection: screening and treatment in an urban setting.
    Morano JP; Walton MR; Zelenev A; Bruce RD; Altice FL
    J Community Health; 2013 Oct; 38(5):941-50. PubMed ID: 23728822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.